| Evvy | Series B | 2026-09-15 | Lead |
| Superluminal Medicines | Series B | 2026-09-03 | |
| Ratio Therapeutics | Series C | 2026-08-03 | |
| Claris Biotherapeutics, Inc. | Series B | 2026-08-03 | Lead |
| Flourish | Funding | 2026-06-05 | |
| Lila Sciences | Series A | 2026-06-04 | |
| 9amHealth | Series B | 2026-05-13 | |
| Imperative Care, Inc. | Convertible Note | 2026-03-18 | |
| ProSomnus | Strategic Investment | 2026-02-19 | |
| Medra | Series A | 2025-12-12 | |
| Beacon Biosignals | Series B | 2025-11-13 | |
| Cartography Biosciences | Series B | 2025-10-02 | Lead |
| Leo Cancer Care | Funding | 2025-09-29 | |
| Ensoma | Funding | 2025-09-23 | |
| Amalgam Rx | Investment | 2025-08-12 | |
| Visby Medical | Funding | 2025-06-19 | Lead |
| Imbria Pharmaceuticals | Series B | 2025-04-11 | |
| Perceive Pharma | Series A | 2025-02-18 | Lead |
| Orasis Pharmaceuticals | Funding | 2024-10-08 | |
| Clasp Therapeutics | Financing | 2024-03-20 | Lead |
| FogPharma | Series E Funding | 2024-03-03 | |
| NextPoint Therapeutics | Series B Extension | 2024-02-15 | Lead |
| Lassen Therapeutics | Series B | 2023-12-20 | |
| Star Therapeutics | Series C Funding | 2023-09-05 | Lead |
| Septerna | Series B Financing | 2023-07-17 | |
| ArriVent Biopharma | Series B Financing | 2023-03-27 | |
| SetPoint Medical | Funding | 2023-01-19 | |
| Spiral Therapeutics, Inc. | Financing | 2023-01-09 | Lead |
| Perceive Biotherapeutics | Series B | 2023-01-06 | |
| Odyssey Therapeutics | Series B | 2022-10-13 | |